Materialise CEO Calls for Common Approach in Measuring Clinical Evidence for Medical 3D Printing (press release)
For more... read my interview with Materialize CEO
Read list of 3D Printers in Orthopedics
CEO states that an evidence-based approach is necessary for medical 3D printing to gain the regulatory acceptance needed to be able to help more patients and save lives.
Orlando, Florida – May 5, 2016. Fried Vancraen, CEO of Materialise NV (Nasdaq: MTLS), the leading provider of Additive Manufacturing software and sophisticated 3D Printing solutions in the medical and industrial markets, calls upon industry stakeholders to come to an agreement for a common standard for measuring the clinical, economical and patient benefits of medical 3D printing in delivering better patient outcomes. Materialise will be leading this on-going initiative as the founding sponsor of the Building Evidence for 3D Printing Applications in Medicine event hosted by SME.
It is becoming increasingly clear that 3D printed anatomical models, guides and implants will be part of the future of patient treatment, for more than just complex procedures. But, unlike the mass-produced medical device industry, adop...
